Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Brimonidine (Exclusively Edp), Atc S01ea05 for the Period February 1St, 202... Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Brimonidine (Exclusively Edp), Atc S01ea05 for the Period February 1St, 2024 - January 31St, 2026 Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, seeet a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicinal products to be specified by the bidder in Annex 2 to the contract in relation to the above. Active ingredient, brimonidine (exclusively EDP), ATC S01EA05, beabsencourages DAK-Gesundheit to conclude drug discount agreements with as many interested pharmaceutical companies as possible until new drug discount agreements come into force. A discount contract in the form of an approval model for the above-mentioned. Active ingredient comes into force for the first time on February 1st, 2024 and endset on January 31, 2026. Regardless, it ends automatically when the exclusive contract comes into force. Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient brimonidine (exclusively EDP), ATC S01EA05 for the period February 1st, 2024 - January 31st, 2026 Doc Title: Conclusion of a nNon-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient brimonidine (exclusively EDP), ATC S01EA05 for the period February 1st, 2024 - January 31st, 2026 Contract Type: supplies DAK HEALTH Address : Nagelsweg 27-31 Town : Hamburg NUTS-Code : DE - Deutschland Postal Code : 20097 Phone : +49 4023648553000 Fax : +49 4033470-900200 vergabestelle@dak.de Tender Notice International Competitive Bidding 766694-2023 Germany GT-93908975

Germany